Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,404,008 | 1,403,688 | 1,367,907 | 1,425,059 | 1,384,419 |
| Marketable Securities | 1,814,508 | 1,687,257 | 1,646,284 | 1,651,617 | 1,588,220 |
| Receivables | 669,870 | 554,268 | 480,600 | 540,622 | 509,265 |
| Other current assets | 1 | 0 | -1 | 0 | 0 |
| TOTAL | $3,888,387 | $3,645,213 | $3,494,790 | $3,617,298 | $3,481,904 |
| Non-Current Assets | |||||
| PPE Net | 100,257 | 97,812 | 95,306 | 98,801 | 92,464 |
| Investments And Advances | 20,972 | 28,743 | 36,041 | 59,026 | 93,098 |
| Intangibles | 27,060 | 30,888 | 35,287 | 40,411 | 43,615 |
| Other Non-Current Assets | 115,140 | 126,412 | 95,607 | 102,620 | 92,940 |
| TOTAL | $263,429 | $283,855 | $262,241 | $300,858 | $322,117 |
| Total Assets | $4,151,816 | $3,929,068 | $3,757,031 | $3,918,156 | $3,804,021 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 260,047 | 225,225 | 188,952 | 235,468 | 201,739 |
| Other current liabilities | 812 | 858 | N/A | N/A | N/A |
| TOTAL | $404,276 | $277,992 | $201,921 | $249,469 | $290,238 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,465 | 3,718 | 3,921 | 4,137 | 4,124 |
| Other Non-Current Liabilities | 75,903 | 80,509 | 55,645 | 59,822 | 60,744 |
| TOTAL | $140,847 | $150,150 | $129,085 | $137,303 | $137,982 |
| Total Liabilities | $545,124 | $428,142 | $331,006 | $386,772 | $428,220 |
| Shareholders' Equity | |||||
| Common Shares | 8,930 | 9,438 | 9,953 | 10,501 | 10,468 |
| Retained earnings | 1,934,655 | 1,750,749 | 1,585,210 | 1,594,182 | 1,449,445 |
| Other shareholders' equity | 20,430 | 15,730 | 14,627 | 12,887 | 13,322 |
| TOTAL | $3,606,692 | $3,500,926 | $3,426,025 | $3,531,384 | $3,375,801 |
| Total Liabilities And Equity | $4,151,816 | $3,929,068 | $3,757,031 | $3,918,156 | $3,804,021 |